The U.S. Food and Drug Administration recently expanded approval of the nasal spray SPRAVATO, a ketamine-derived drug, as a treatment for depression. A clinic in Denver is looking to help those ...

This nasal spray vaccine can be self-administered or given by a caregiver, potentially increasing vaccination rates and accessibility.

Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, today announced the filing of a ...

The “life-changing” drug, Acarizax, works by delivering a fixed amount of house dust mite allergy extract every day to help ...

The NHS will now offer immunotherapy pill Acarizax so the body can become less sensitive to dust mites over time and halt ...

The city has installed Narcan kits at public locations after receiving them as a donation from Mothers for Awareness and ...

The results, which come on the heels of the FDA’s approval of J&J’s esketamine nasal spray Spravato as a monotherapy for ...

IT’S that time of year again when we’re seemingly greeted with a new cough, sneeze or sniffle every week. But as we beat one ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

Chris Cavallo & Daughter Cristina Cavallo Co Founder's of The Robin Foundation Walk for Lives The Robin Foundation The Robin ...

Kenox Pharmaceuticals Inc (Kenox), a fast-growing company dedicated to developing innovative Orally Inhaled and Nasal Drug Products (OINDPs), is proud to announce the addition of small scale ...

The FDA has approved the use of Spravato, an antidepressant nasal spray, as a standalone treatment for depression in the U.S. Sue Varma discusses why she supports the use of the drug and how it may ...